We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.68B
AUM Growth
+$211M
Cap. Flow
-$41.5M
Cap. Flow %
-1.13%
Top 10 Hldgs %
18.5%
Holding
337
New
20
Increased
84
Reduced
184
Closed
17

Top Buys

Rank Stock Value
1
MYRG icon
MYR Group
MYRG
+$10.4M
2
TITN icon
Titan Machinery
TITN
+$9.81M
3
COLB icon
Columbia Banking Systems
COLB
+$9.42M
4
LTHM
Livent Corporation
LTHM
+$8.95M
5
PK icon
Park Hotels & Resorts
PK
+$8.92M

Top Sells

Rank Stock Value
1
AMN icon
AMN Healthcare
AMN
+$13.2M
2
MDC
M.D.C. Holdings, Inc.
MDC
+$12.3M
3
DOC
PHYSICIANS REALTY TRUST
DOC
+$10.3M
4
AUB icon
Atlantic Union Bankshares
AUB
+$10M
5
SHO icon
Sunstone Hotel Investors
SHO
+$9.81M

Sector Composition

Rank Sector Weight
1 Technology 23.47%
2 Healthcare 18%
3 Financials 14%
4 Consumer Discretionary 12.52%
5 Industrials 12.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECPG icon
226
Encore Capital Group
ECPG
$1.98B
$6.36M 0.17%
130,858
-5,409
-4% -$263K
BV icon
227
BrightView Holdings
BV
$1.05B
$6.33M 0.17%
881,355
-36,417
-4% -$230K
PAR icon
228
PAR Technology
PAR
$723M
$6.31M 0.17%
191,559
+890
+0.5% +$29.7K
CHRS icon
229
Coherus Oncology
CHRS
$187M
$6.14M 0.17%
1,437,553
+370,369
+35% +$2.19M
IONS icon
230
Ionis Pharmaceuticals
IONS
$9.22B
$6.12M 0.17%
149,198
-49
-0% -$1.88K
VIRT icon
231
Virtu Financial
VIRT
$4.87B
$6.09M 0.17%
356,157
-62
-0% -$1.14K
CYTK icon
232
Cytokinetics
CYTK
$10.6B
$5.9M 0.16%
180,728
-18,688
-9% -$691K
SRI icon
233
Stoneridge
SRI
$195M
$5.89M 0.16%
312,640
-12,895
-4% -$226K
CDMO
234
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$5.7M 0.16%
408,086
-140
-0% -$2.39K
AZTA icon
235
Azenta
AZTA
$1.54B
$5.57M 0.15%
119,396
-43
-0% -$1.88K
VSXY
236
Victoria's Secret
VSXY
$7.5B
$5.23M 0.14%
300,188
-12,396
-4% -$312K
RBA icon
237
RB Global
RBA
$16.6B
$5.12M 0.14%
85,397
-51
-0.1% -$2.88K
SYNA icon
238
Synaptics
SYNA
$4.18B
$5.06M 0.14%
59,308
-18
-0% -$1.56K
APPS icon
239
Digital Turbine
APPS
$1.59B
$4.94M 0.13%
532,819
+96,204
+22% +$1.06M
SNDX icon
240
Syndax Pharmaceuticals
SNDX
$1.81B
$4.89M 0.13%
+233,738
New +$4.87M
MNRO icon
241
Monro
MNRO
$365M
$4.7M 0.13%
115,793
-37
-0% -$1.67K
TNDM icon
242
Tandem Diabetes Care
TNDM
$1.62B
$4.67M 0.13%
190,458
-58
-0% -$1.87K
SRPT icon
243
Sarepta Therapeutics
SRPT
$1.92B
$4.58M 0.12%
40,012
-30,565
-43% -$3.94M
SWTX
244
DELISTED
SpringWorks Therapeutics
SWTX
$4.44M 0.12%
169,493
-50
-0% -$1.31K
LUCK
245
Lucky Strike Entertainment
LUCK
$893M
$3.94M 0.11%
+338,165
New +$4.51M
VTYX
246
DELISTED
Ventyx Biosciences
VTYX
$3.3M 0.09%
+100,485
New +$3.46M
ADPT icon
247
Adaptive Biotechnologies
ADPT
$4.04B
$3.14M 0.09%
467,286
-109
-0% -$810
MANH icon
248
Manhattan Associates
MANH
$11.4B
$2.04M 0.06%
10,214
+404
+4% +$70.2K
NOVT icon
249
Novanta
NOVT
$6.34B
$1.69M 0.05%
9,202
+1,519
+20% +$248K
MTZ icon
250
MasTec
MTZ
$21.8B
$1.66M 0.05%
14,105
+2,417
+21% +$237K
8 9
10
11 12

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Peregrine Capital Management held 337 positions worth $3.68B, up 6.1% from $3.47B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Peregrine Capital Management's Q2 2023 filing shows 20 new, 84 increased, 184 reduced and 17 closed positions. Its largest new stake was MYR Group: 79,706 shares worth $11M. The largest sale was AMN Healthcare, an estimated $13.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q2 2023 buy was MYR Group: 79,706 shares worth $11M.
  • Peregrine Capital Management added most to Columbia Banking Systems in Q2 2023, an estimated $9.42M increase.
  • Peregrine Capital Management's biggest Q2 2023 reduction was AMN Healthcare, cutting an estimated $13.2M.
  • Peregrine Capital Management fully exited PHYSICIANS REALTY TRUST in Q2 2023, selling an estimated $10.3M.
  • Peregrine Capital Management's ten largest holdings make up 18% of its $3.68B portfolio in Q2 2023.
  • Peregrine Capital Management opened 20 new positions and closed 17 in Q2 2023.
  • Peregrine Capital Management's portfolio value rose 6.1% quarter-over-quarter to $3.68B.

Based on Peregrine Capital Management's 13F filing for Q2 2023, filed 26 Jul 2023.